Literature DB >> 12822623

Predictors of residual tricuspid regurgitation after mitral valve surgery.

Katsuhiko Matsuyama1, Masahiko Matsumoto, Takaaki Sugita, Junichiro Nishizawa, Yoshiyuki Tokuda, Takehiko Matsuo.   

Abstract

BACKGROUND: Whether preoperative tricuspid regurgitation (TR) will regress or progress late after surgery is unknown. The aim of this study was to evaluate predictors of significant TR late after mitral valve surgery.
METHODS: A retrospective analysis was performed on a total of 174 patients who underwent mitral valve surgery without tricuspid valve surgery. Preoperatively, 46 patients (26%) had 2+ TR, and 128 patients (74%) had 1+ or less TR. Postoperative 3+ TR was considered significant TR. Variables were used to evaluate predictors of TR development by univariate or multivariate analysis.
RESULTS: The mean follow-up was 8.2 years (range 1.0 to 14.5 years) after surgery. There was progressive TR (3+ or more) in 28 patients (16%) during the follow-up period. In univariate analysis, atrial fibrillation, rheumatic etiology, huge left atrium, left ventricular dysfunction, and preoperative 2+ TR were significant risk factors for TR development. Multivariate analysis identified preoperative 2+ TR, atrial fibrillation, and huge left atrium as statistically significant predictors for late TR after surgery.
CONCLUSIONS: Aggressive repair of accompanying TR should be undertaken at the time of initial surgery in patients with huge left atrium or atrial fibrillation, even if preoperative TR is 2+.

Entities:  

Mesh:

Year:  2003        PMID: 12822623     DOI: 10.1016/s0003-4975(03)00028-6

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  38 in total

Review 1.  Tricuspid regurgitation: pathophysiology and management.

Authors:  Rashmi Thapa; Buddhadeb Dawn; Jayant Nath
Journal:  Curr Cardiol Rep       Date:  2012-04       Impact factor: 2.931

2.  Predictors of secondary tricuspid regurgitation after left-sided valve replacement.

Authors:  Guohua Wang; Zongquan Sun; Jiahong Xia; Yongzhi Deng; Jiajun Chen; Gang Su; Youli Ke
Journal:  Surg Today       Date:  2008-08-28       Impact factor: 2.549

Review 3.  Tricuspid valve repair for treatment and prevention of secondary tricuspid regurgitation in patients undergoing mitral valve surgery.

Authors:  Ani C Anyanwu; Joanna Chikwe; David H Adams
Journal:  Curr Cardiol Rep       Date:  2008-03       Impact factor: 2.931

Review 4.  Non-functional tricuspid valve disease.

Authors:  Dale S Adler
Journal:  Ann Cardiothorac Surg       Date:  2017-05

5.  Continuous "over and over" suture for tricuspid ring annuloplasty.

Authors:  Kwon-Jae Park; Jong Soo Woo; Sang Seok Jeong; Jung Hoon Yi
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2012-02-07

Review 6.  Evidence-based surgical management of acquired tricuspid valve disease.

Authors:  Sung Ho Shinn; Hartzell V Schaff
Journal:  Nat Rev Cardiol       Date:  2013-02-12       Impact factor: 32.419

Review 7.  [Tricuspid valve regurgitation : Indications and operative techniques].

Authors:  R Lange; N Piazza; T Günther
Journal:  Herz       Date:  2017-11       Impact factor: 1.443

8.  Prognostic implications of tricuspid regurgitation in patients with severe aortic regurgitation: results from a cohort of 756 patients.

Authors:  Padmini Varadarajan; Ramdas G Pai
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-02-17

9.  Mild to moderate functional tricuspid regurgitation: retrospective comparison of surgical and conservative treatment.

Authors:  Michal Smíd; Jakub Cech; Richard Rokyta; Patrik Roucka; Tomás Hájek
Journal:  Cardiol Res Pract       Date:  2010-08-02       Impact factor: 1.866

10.  Outcomes of Guideline-Directed Concomitant Annuloplasty for Functional Tricuspid Regurgitation.

Authors:  Alexander A Brescia; Sarah T Ward; Tessa M F Watt; Liza M Rosenbloom; Megan Baker; Shazli Khan; Emilie Ziese; Matthew A Romano; Steven F Bolling
Journal:  Ann Thorac Surg       Date:  2019-08-31       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.